Pfizer Settles Viagra Patent Litigation With Teva…Bit of a Letdown

Viagra

NEW YORK, Dec 17, 2013 (BUSINESS WIRE) — Pfizer Inc. announced that it has settled its litigation against Teva Pharmaceuticals, USA Inc., relating to Pfizer’s patent covering the use of Viagra(R) to treat erectile dysfunction (sildenafil citrate 25, 50, and 100 mg tablets), which expires in April 2020 (including pediatric exclusivity). As a result of the settlement, Teva will be allowed to launch a generic version of Viagra(R) in the United States on December 11, 2017, or earlier under certain circumstances. Teva will pay Pfizer a royalty for a license to produce its generic version. The terms of the settlement agreement are otherwise confidential. Teva has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Viagra(R).

Teva obtains a licence to launch before patent term runs out. Pediatiric exclusivity? What are kids taking this for?

One Response to Pfizer Settles Viagra Patent Litigation With Teva…Bit of a Letdown

  1. ziola na potencje

    Pfizer Settles Viagra Patent Litigation With Teva…Bit of a Letdown | The IP Factor

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: